# LSK BioPartners, Inc. — Form D

LSK BioPartners, Inc. of SALT LAKE CITY, UT, a company, filed a Form D exempt-offering notice with the SEC on 2018-08-01. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2018-08-01
- Form: D
- Accession: 0001748803-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $20.0M
- Investors: 1
- Date of first sale: 2018-07-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-318276

## Issuer

- Name: LSK BioPartners, Inc.
- CIK: 0001748803
- Entity type: Corporation
- Jurisdiction: UTAH
- Address: 2825 E Cottonwood Pkwy, SALT LAKE CITY, UT, 84121
- Phone: 801-303-7440

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Weili Cheng | Director | Salt Lake City, UT |
| Alex Kim | Director | Long Island City, NY |
| Sung Chul Kim | Director | Salt Lake City, UT |
| Sung Chul Kim | Executive Officer | Salt Lake City, UT |
| Ha Young Kim | Director | Salt Lake City, UT |
| Anton Gueth | Director | Salt Lake City, UT |
| Soo Whan Choi | Director | Salt Lake City, UT |
| Soo Whan Choi | Executive Officer | Salt Lake City, UT |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2019-05-10](https://search.stillhousedata.com/formd/0001748803-19-000001) | D | $20.0M | $20.0M |

## More

- [CIK 1748803 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1748803&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001748803-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.